What's the recommended lurbinectedin dosage for adults?

What determines the lurbinectedin dose for adults

Lurbinectedin is dosed at 3.2 mg per square meter of body surface area, given as a 60-minute infusion every 21 days. The calculation requires body surface area in square meters, which medics use to scale the dose to each patient’s size.

How do doctors adjust the dose if blood counts drop

Doctors reduce the dose to 2.6 mg/m² when absolute neutrophil count falls below 500 cells/mm³ or when platelets drop to less than 50,000/mm³. Further reductions to 2.0 mg/m² occur if counts remain low after the previous reduction.

Why are labs checked before each cycle

Labs are drawn before every dose to confirm absolute neutrophil count reaches at least 1,500 cells/mm³ and platelets reach at least 100,000/mm³ before proceeding. Labs also track liver enzymes and creatinine clearance to keep within safe ranges.

Can lurbinectedin be used in patients with liver impairment

For moderate hepatic impairment, doctors start at 2.0 mg/m². Severe hepatic impairment is a contraindication. Mild impairment requires no adjustment.

What happens if a dose is missed or delayed

A missed or delayed dose is simply rescheduled as the next regular cycle without doubling up. Patients should inform their care team immediately if they miss a cycle.

What side effects prompt patients to ask about dose changes

Common concerns include low white blood cell counts, fatigue, increased liver enzymes, and nausea. These values or symptoms lead clinicians to hold or reduce the dose until recovery.

Who manufactures lurbinectedin and does it have patents

Jazz Pharmaceuticals markets lurbinectedin under the brand name Zepzelca. [1]